Santander Javier, Wanda Soo-Young, Nickerson Cheryl A, Curtiss Roy
The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University, PO Box 875401, 1001 S. McAllister Avenue, Tempe, AZ 85287-5401, USA.
Infect Immun. 2007 Mar;75(3):1382-92. doi: 10.1128/IAI.00888-06. Epub 2006 Dec 18.
Regulation of the synthesis of Vi polysaccharide, a major virulence determinant in Salmonella enterica serotype Typhi, is under the control of two regulatory systems, ompR-envZ and rscB-rscC, which respond to changes in osmolarity. Some serotype Typhi strains exhibit overexpression of Vi polysaccharide, which masks clinical detection of lipopolysaccharide O antigen. This variation in Vi polysaccharide and O antigen display (VW variation) has been observed since the initial studies of serotype Typhi. In this study, we report that rpoS plays a role in this increased expression in Vi polysaccharide. We constructed a variety of isogenic serotype Typhi mutants that differed in their expression levels of RpoS and examined the role of the rpoS product in synthesis of Vi polysaccharide under different osmolarity conditions. Vi polysaccharide synthesis was also examined in serotype Typhi mutants in which the native promoter of the rpoS was replaced by an araCP(BAD) cassette, so that the expression of rpoS was arabinose dependent. The RpoS(-) strains showed increased syntheses of Vi polysaccharide, which at low and medium osmolarities masked O antigen detection. In contrast, RpoS(+) strains showed lower syntheses of Vi polysaccharide, and an increased detection of O antigen was observed. During exponential growth, when rpoS is unstable or present at low levels, serotype Typhi RpoS(+) strains overexpress the Vi polysaccharide at levels comparable to those for RpoS(-) strains. Our results show that RpoS is another regulator of Vi polysaccharide synthesis and contributes to VW variation in serotype Typhi, which has implications for the development of recombinant attenuated Salmonella vaccines in humans.
Vi多糖是伤寒沙门氏菌主要的毒力决定因素,其合成受两个响应渗透压变化的调控系统ompR - envZ和rscB - rscC的控制。一些伤寒血清型菌株表现出Vi多糖的过表达,这掩盖了脂多糖O抗原的临床检测。自对伤寒血清型的初步研究以来,就已观察到Vi多糖和O抗原表现的这种变化(VW变化)。在本研究中,我们报告rpoS在Vi多糖的这种表达增加中起作用。我们构建了多种RpoS表达水平不同的同基因伤寒血清型突变体,并研究了rpoS产物在不同渗透压条件下Vi多糖合成中的作用。还在将rpoS的天然启动子替换为araCP(BAD)盒的伤寒血清型突变体中检测了Vi多糖的合成,这样rpoS的表达就依赖于阿拉伯糖。RpoS( - )菌株显示Vi多糖合成增加,在低渗透压和中等渗透压下掩盖了O抗原的检测。相比之下,RpoS( + )菌株显示Vi多糖合成较低,并且观察到O抗原检测增加。在指数生长期间,当rpoS不稳定或水平较低时,伤寒血清型RpoS( + )菌株Vi多糖的过表达水平与RpoS( - )菌株相当。我们的结果表明,RpoS是Vi多糖合成的另一个调节因子,并导致伤寒血清型的VW变化,这对人类重组减毒沙门氏菌疫苗的开发具有重要意义。